⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 23, 2024Journal of Alzheimer s DiseaseOpen Access

The Memory Binding Test Detects Early Subtle Episodic Memory Decline in Preclinical Alzheimer’s Disease: A Longitudinal Study

Filipa Rapos Pereira Nathalie George Gianfranco Dalla Barba Bruno Dubois Valentina La Corte

View Full Paper

Ask AI

Bookmark

Share

Abstract

The asymptomatic at-risk phase might be the optimal time-window to establish clinically meaningful endpoints in Alzheimer's disease (AD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pereira et al. (2024) studied this question.

synapsesocial.com/papers/68e77de8b6db6435876f188b https://doi.org/10.3233/jad-230921

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Time restricted eating through self-regulatory behaviors for metabolic and cognitive health in mild cognitive impairment: Feasibility and acceptability findings from the TEMPO trialJournal of Alzheimer s Disease · Thu,
2VIDESTA: Adaptation of the BSL-CST for cognitive screening in the Austrian deaf sign language communityJournal of Alzheimer s Disease · Wed,
3Italian norms for two brief visuospatial tests: Qualitative Scoring Pentagon Test and Benton Judgment of Line Orientation - Short FormJournal of Alzheimer s Disease · Thu,
4Diagnostic reclassification under the AA-2024 biological framework: A real-world comparison with ATN 2018 using cerebrospinal fluid biomarkersJournal of Alzheimer s Disease · Thu,
5Neuronal maturation is altered during pre-pathological stages in the App NL-F mouse model of Alzheimer's diseaseJournal of Alzheimer s Disease · Thu,

More from Journal of Alzheimer s Disease

Clusters of modifiable dementia risk factors at mid-life and late-life and their association with incident dementia: A prospective cohort study of 246,968 adultsThu,
Comparing operational definitions of screening-based cognitive impairment in the Tohoku Medical Megabank cohort: Focus on digital engagementMon,
Immunoglobulin GM (γ marker) allotypes as potential genetic markers of efficacy of lecanemab therapy in Alzheimer's diseaseFri,
Association between handedness and Alzheimer's disease: Results from a large MindCrowd observational studyFri,
Lower cardiac output is associated with longitudinal decreases in cerebrospinal fluid amyloid-β42, a core Alzheimer's disease biomarker, in women but not menFri,